Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;13(5):1110-1120.
doi: 10.1002/1878-0261.12470. Epub 2019 Mar 1.

A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers

Affiliations

A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers

Juan Miguel Baquero et al. Mol Oncol. 2019 May.

Abstract

Single nucleotide polymorphisms (SNPs) in DNA glycosylase genes involved in the base excision repair (BER) pathway can modify breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We previously found that SNP rs34259 in the uracil-DNA glycosylase gene (UNG) might decrease ovarian cancer risk in BRCA2 mutation carriers. In the present study, we validated this finding in a larger series of familial breast and ovarian cancer patients to gain insights into how this UNG variant exerts its protective effect. We found that rs34259 is associated with significant UNG downregulation and with lower levels of DNA damage at telomeres. In addition, we found that this SNP is associated with significantly lower oxidative stress susceptibility and lower uracil accumulation at telomeres in BRCA2 mutation carriers. Our findings help to explain the association of this variant with a lower cancer risk in BRCA2 mutation carriers and highlight the importance of genetic changes in BER pathway genes as modifiers of cancer susceptibility for BRCA1 and BRCA2 mutation carriers.

Keywords: BRCA2; DNA damage; cancer risk modifier; oxidative stress susceptibility; telomere damage; uracil-DNA glycosylase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
UNG mRNA and protein levels. (A) UNG mRNA levels in the various FBOC groups according to the presence or absence of the SNP [noncarriers (GG)/carriers (GC/CC)]. (B) UNG1 protein levels in controls (n = 10) and BRCA2 mutation carriers (n = 20) according to the presence or absence of the SNP [noncarriers (GG)/carriers (GC/CC)]. Actin levels were used to normalize for protein loading. (C) Quantification of UNG1 protein levels of the western blot shown in (B). Bars show the mean and the standard error of the mean (SEM). Numbers in brackets indicate sample size. (D) Correlation analysis between UNG1 mRNA and protein levels in the patients shown in (B). Unpaired t‐tests were performed for statistical significance in (A) and (C), Spearman's test was used to test the significance of the correlation in panel (D).
Figure 2
Figure 2
Telomere DNA damage in the various FBOC groups according to the presence or absence of the UNG SNP. (A) DNA oxidation at telomeres. (B) Detection of uracil at telomeres in FBOC patients. Bars show the mean and the SEM. Numbers in brackets indicate sample size. Mann–Whitney U‐test was used in (A), unpaired t‐test was used in (B).
Figure 3
Figure 3
Immunodetection of protein‐bound carbonyl groups in plasma samples from the FBOC series. Carbonylation levels in the different groups stratified according to the presence or absence of SNP rs34259 in UNG [noncarriers (GG)/carriers (GC/CC)]. Bars show the mean and the SEM. Numbers in brackets indicate sample size. Unpaired t‐tests were performed for statistical significance. A.U., arbitrary units.
Figure 4
Figure 4
Telomere length and percentage of short telomeres. (A) Distribution of telomere length (kb) values adjusted for age in the FBOC series according to the presence or absence of the UNG SNP [noncarriers (GG)/carriers (GC/CC)]. (B) Comparative analysis of FBOC groups regarding the percentage of short (< 3 kb) telomeres. Bars show the mean and the SEM. Numbers in brackets indicate sample size. Unpaired t‐tests were performed for statistical significance.

References

    1. Akbari M, Otterlei M, Peña‐Diaz J and Krokan HE (2007) Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil‐DNA glycosylase after oxidative stress. Neuroscience 145, 1201–1212. - PubMed
    1. Amos CI, Dennis J, Wang Z, Byun J, Schumacher FR, Gayther SA, Casey G, Hunter DJ, Sellers TA, Gruber SB et al (2017) The Oncoarray Consortium: a network for understanding the genetic architecture of common cancers. Cancer Epidemiol Biomarkers Prev 26, 26–36. - PMC - PubMed
    1. Ardlie KG, Deluca DS, Segre AV, Sullivan TJ, Young TR, Gelfand ET, Trowbridge CA, Maller JB, Tukiainen T, Lek M et al (2015) The Genotype‐Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660. - PMC - PubMed
    1. Benítez‐Buelga C, Baquero JM, Vaclová T, Fernández V, Martín P, Inglada‐Pérez L, Urioste M, Osorio A and Benítez J (2017) Genetic variation in the NEIL2 DNA glycosylase gene is associated with oxidative DNA damage in BRCA2 mutation carriers. Oncotarget 8, 114626–114636. - PMC - PubMed
    1. Benítez‐Buelga C, Sanchez‐Barroso L, Gallardo M, Apellániz‐Ruiz M, Inglada‐Pérez L, Yanowski K, Carrillo J, Garcia‐Estevez L, Calvo I, Perona R et al (2015) Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients. Breast Cancer Res Treat 149, 385–394. - PMC - PubMed

Publication types